Adult urologyRelationship of tumor DNA-ploidy toserum prostate-specific antigen doubling time after radiotherapy for prostate cancer
References (31)
- et al.
Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy
J Urol
(1991) - et al.
Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate
Urology
(1993) - et al.
Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup
J Urol
(1993) - et al.
Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome
J Urol
(1994) - et al.
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
J Urol
(1988) - et al.
Prostate-specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer
J Urol
(1992) - et al.
Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy?
J Urol
(1993) - et al.
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years
Urol Clin North Am
(1993) - et al.
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
J Urol
(1989) - et al.
Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time
Int J Radiat Oncol Biol Phys
(1993)
Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localizedprostate carcinoma treated by external beam radiotherapy
J Urol
(1992)
The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy
Int J Radiat Oncol Biol Phys
(1994)
Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis
Mayo Clin Proc
(1989)
Prostatespecific antigen and external beam radiotherapy in prostate cancer
Cancer
(1991)
Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer
J Clin Oncol
(1992)
Cited by (23)
PSA and follow-up after treatment of prostate cancer
2008, Progres en UrologieCell ploidy: Predictive factor of locally advanced prostate cancer
2007, Progres en UrologieThe cancer recognition (CARE) antibody test
2004, Cancer LettersPrognostic value of DNA ploidy in prostatic cancer
2001, Actas urologicas españolas
This study was supported in part by grants CA-06294 and CA-16672 awarded by the National Cancer Institute, U.S. Department of Health and Human Services; by the Katherine Unsworth Lead Annuity Trust; and by a University of Texas M.D. Anderson Executive Council Grant.
Copyright © 1994 Published by Elsevier Inc.